13D/13G Filings - PLATINUM INVESTMENT MANAGEMENT LTD

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-06
7:56 pm
Unchanged
2024-09-3013GNanoString Technologies, Inc.
NSTGQ
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2024-11-06
7:53 pm
Unchanged
2024-09-3013GKazia Therapeutics Limited
KZIA
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2024-11-06
7:47 pm
Unchanged
2024-03-3113GCENTOGENE N V COM SHS USD
CNTGF
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2024-02-13
10:37 am
Unchanged
2023-12-3113GIcosavax, Inc.
ICVX
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2024-02-12
6:35 pm
Unchanged
2023-12-3113GKazia Therapeutics Limited
KZIA
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2024-02-12
6:13 pm
Unchanged
2023-12-3113GNanoString Technologies, Inc.
NSTGQ
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2023-02-09
10:31 am
Unchanged
2022-12-3113GIcosavax, Inc.
ICVX
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2022-02-10
5:25 pm
Unchanged
2021-12-3113GEsperion Therapeutics, Inc.
ESPR
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2021-12-08
8:52 pm
Unchanged
2021-11-3013GCENTOGENE N V COM SHS USD
CNTGF
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing
History
2021-02-11
7:45 pm
Unchanged
2021-02-1113GEsperion Therapeutics, Inc.
ESPR
PLATINUM INVESTMENT MANAGEMENT LTD0
0.000%
0
(Unchanged)
Filing